Defining the Target and the Effect of Imatinib on the Filarial C-Abl Homologue

PLoS Neglected Tropical Diseases - United States
doi 10.1371/journal.pntd.0005690
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Defining the Tumour and Target Volumes for Radiotherapy

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2004English

Phenotypic and Molecular Analysis of the Effect of 20-Hydroxyecdysone on the Human Filarial Parasite Brugia Malayi

International Journal for Parasitology
ParasitologyInfectious Diseases
2016English

C-Jun Regulates the Stability and Activity of the P53 Homologue, P73

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Imatinib May Be ABL to Improve Anti-Angiogenic Therapy

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2015English

Characteristics of the TCR Vβ Repertoire in Imatinib-Resistant Chronic Myeloid Leukemia Patients With ABL Mutations

Science China Life Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryBiological SciencesAgricultural
2015English

ON012380: A Non-Atp Competitive Inhibitor of BCR-ABL for the Therapy of Imatinib-Resistant CMLs

2009English

Current State and the Future of Molecular Target Drugs: Lessons Learned From the Success of Imatinib

Folia Pharmacologica Japonica
Pharmacology
2008English

A Non-Atp-Competitive Inhibitor of BCR-ABL Overrides Imatinib Resistance

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

An Amino-Acid Switch in the BCR-ABL Kinase Domain Modifies Sensitivity to Imatinib Mesylate

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy